￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
The combination of azacitidine/ruxolitinib tablets can prolong the survival of patients with advanced MPNs

2026-02-01 22:25:32

Check Details
Clinical efficacy of clofazimine in the treatment of leprosy

2026-02-01 22:25:32

Check Details
Information about pharmaceutical companies that develop and produce Enasidenib

2026-02-01 22:25:32

Check Details
Does evantuzumab/Carestream have any effect on the heart?

2026-02-01 22:25:32

Check Details
Enzalutamide/enzalutamide is produced and developed by which company?

2026-02-01 22:25:32

Check Details
Copanlisib/ibrutinib data highlight potential of PI3K inhibition in R/R PCNSL

2026-02-01 22:25:32

Check Details
What are the indications for Ruxolitinib Tablets/Jiekewei?

2026-02-01 22:25:32

Check Details
Recommended combination regimens commonly used for clofazimine

2026-02-01 22:25:32

Check Details
Detailed analysis of the drug ingredients of Enasidenib

2026-02-01 22:25:32

Check Details
PALOMA-2: Patient experience after intravenous evantumumab in patients with advanced EGFR-mutated non-small cell lung cancer

2026-02-01 22:25:32

Check Details
Is there a big difference between domestic and imported drugs of enzalutamide/enzalutamide?

2026-02-01 22:25:32

Check Details
Analysis of how long it takes for Axitinib (Inlida) to take effect and the reasons for the difference in onset time

2026-02-01 22:25:32

Check Details
Category
相关知识